Verifying…
Home / Drug A–Z / Fortsporine Injection 1 g

Fortsporine Injection 1 g

NAFDAC Reg. No. A4-6768 · Drug

Registered with NAFDAC — registration activeAs of 6 November 2026 · synced automatically from official sources.
Product
Fortsporine Injection 1 g
NAFDAC number
A4-6768
Active ingredient
Cefepime (Cefepime Hydrochloride)
Strength
1 g
Form
Powder for injection
Pack size
1 g x 1's (in glass vial) + 10 mL SWFI (in ampoule)
Manufacturer
Not listed
Applicant (holder)
Zolon Healthcare Limited
Approved
3 Aug 2021
Status
Inactive View on NAFDAC ↗
Registration valid to
2 Aug 2026
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Fortsporine Injection 1 g is on the NAFDAC register with an active registration (A4-6768). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Fortsporine Injection 1 g is used for

From the official U.S. FDA label for cefepime (cefepime hydrochloride), the active ingredient registered with NAFDAC.

What it is used for

Cefepime for Injection is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible strains of the designated microorganisms: • Pneumonia. ( 1.1 ) • Empiric therapy for febrile neutropenic patients. ( 1.2 ) • Uncomplicated and complicated urinary tract infections (including pyelonephritis). ( 1.3 ) • Uncomplicated skin and skin structure infections. ( 1.4 ) • Complicated intra-abdominal infections (used in combination with metronidazole) in adults. …

Possible side effects

The following adverse reactions are discussed in the Warnings and Precautions section and below: • Hypersensitivity Reactions [ see Warnings and Precautions (5.1) ] • Neurotoxicity [ see Warnings and Precautions (5.2) ] • Clostridioides difficile -Associated Diarrhea [ see Warnings and Precautions (5.3) ] •The most common adverse reactions (incidence ≥ 1%) were local reactions, positive Coombs’ test, decreased phosphorous, increased ALT and AST, increased PT and PTT and rash. ( 6.1 ) •At the highest dose (2 g every 8 hours), incidence of adverse reactions was ≥1% for rash, diarrhea, nausea, vomiting, pruritis, fever, and headache. …

Do not use if

Cefepime for Injection is contraindicated in patients who have shown immediate hypersensitivity reactions to cefepime or the cephalosporin class of antibacterial drugs, penicillins or other beta-lactam antibacterial drugs. Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. ( 4 )

Warnings

• Hypersensitivity Reactions: Cross-hypersensitivity among beta-lactam antibacterial drugs may occur in up to 10% of patients with a history of penicillin allergy. If an allergic reaction to Cefepime for Injection occurs, discontinue the drug. ( 5.1 ) • Neurotoxicity: May occur especially in patients with renal impairment administered unadjusted doses. If neurotoxicity associated with Cefepime for Injection therapy occurs, discontinue the drug. ( 5.2 ) • Clostridioides difficile -Associated Diarrhea (CDAD): Evaluate if diarrhea occurs. …

Pregnancy & breastfeeding

8.1 Pregnancy Risk Summary There are no cases of Cefepime for Injection exposure during pregnancy reported from postmarketing experience or from clinical trials. Available data from published observational studies and case reports over several decades with cephalosporin use in pregnant women have not established drug-associated risks of major birth defects, miscarriage or adverse maternal or fetal outcomes ( see Data ). …

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Fortsporine Injection 1 g

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Fortsporine Injection 1 g

What is in Fortsporine Injection 1 g?

Fortsporine Injection 1 g contains Cefepime (Cefepime Hydrochloride) (1 g), as powder for injection, according to its NAFDAC registration record.

Is Fortsporine Injection 1 g registered with NAFDAC?

Yes. Fortsporine Injection 1 g is listed on the NAFDAC register under registration number A4-6768, and its registration is active as of 6 November 2026.

Has Fortsporine Injection 1 g been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Fortsporine Injection 1 g in our automatically synced alert list.

How can I check that my pack of Fortsporine Injection 1 g is genuine?

Run a free authenticity scan with the NAFDAC number A4-6768, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Fortsporine Injection 1 g used for?

Cefepime for Injection is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible strains of the designated microorganisms: • Pneumonia. ( 1.1 ) • Empiric therapy for febrile neutropenic patients. ( 1.2 ) • Uncomplicated and complicated urinary tract infections (including pyelonephritis). ( 1.3 ) • Uncomplicated skin and skin structure infections (Summarised from the official U.S. FDA label for cefepime (cefepime hydrochloride). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Fortsporine Injection 1 g? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.